MARIE GARCON: Open Payments
NPI 1861427874 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,578 in 58 payments from 31 companies in 2025. Trend: 2023 $4,903 · 2024 $5,076 · 2025 $6,578
Food & beverage: $6,495Education: $83
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $643 |
| Janssen Biotech, Inc. | 4 | $508 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 3 | $402 |
| ABBVIE INC. | 4 | $395 |
| E.R. Squibb & Sons, L.L.C. | 3 | $389 |
| Sequel Med Tech, LLC | 2 | $329 |
| Grifols USA, LLC | 4 | $315 |
| AstraZeneca Pharmaceuticals LP | 4 | $310 |
| Abbott Laboratories | 2 | $307 |
| Axsome Therapeutics, Inc. | 3 | $307 |
Products named: TREMFYA, COBENFY, TWIIST, FREESTYLE LIBRE 3, Auvelity, INVEGA SUSTENNA, JARDIANCE, VRAYLAR.
Industry payments across NY — which companies pay providers there.
